C.MinnionJ
By integrating the appetite-suppressive effects of GLP-1, the insulin-sensitizing properties of GIP, and the energy expenditureenhancing actions of glucagon, retatrutide is designed to maximize weight loss and metabolic improvement through complementary hormonal pathways
It specifically targets adipose (fat) tissue, promoting fat metabolism and reducing fat accumulation
For example, people with digestive issues may not absorb liquid, gummy, or pill forms of vitamin B12 effectively
With this background, the question becomes how increased GLP1R signaling in these brain areas might explain sex differences in responsiveness to GLP1R agonists
Thus, reduced levels of butyrate and other SCFAs in patients with BD can have important consequences in the intestinal inflammation and permeability